An observational, retrospective analysis evaluating switching to raltegravir plus abacavir/lamivudine in HIV-1-infected patients: the ORASWIRAL study-Reference-Cited by-同舟云学术

An observational, retrospective analysis evaluating switching to raltegravir plus abacavir/lamivudine in HIV-1-infected patients: the ORASWIRAL study

Published:2017-09-11 Issue:3 Volume:50 Page:220-222
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Galli Laura¹,Poli Andrea¹,Muccini Camilla¹²,Galizzi Nadia¹²,Danise Anna¹,Spagnuolo Vincenzo²,Gianotti Nicola¹,Carini Elisabetta¹,Lazzarin Adriano¹²,Castagna Antonella¹²

Affiliation:

1. Infectious Diseases, IRCCS San Raffaele, Milano, Italy;

2. Università Vita-Salute San Raffaele, Milano, Italy

Funder

MSD Italia

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2017.1374552

Reference10 articles.

1. Antiretroviral treatment for HIV infection: Swedish recommendations 2016

2. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2013. Available at: http://www.who.int/hiv/pub/guidelines/arv2013/download/en/.

3. FDA. Drug Approval Package: Isentress (raltegravir). 2007. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022145_Isentress.cfm.

4. European Medicines Agency. Isentress (raltegravir). 2008. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000860/human_med_000859.jsp&mid=WC0b01ac058001d124.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efectividad y seguridad del cambio a esquema basado en raltegravir en pacientes con infección por VIH dislipidémicos bajo terapia anti-retroviral en Fundación Arriarán;Revista chilena de infectología;2019-08

2. Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study;International Journal of STD & AIDS;2019-01-10

3. Alternative switching strategies based on regimens with a low genetic barrier: do clinicians have a choice nowadays?;European Journal of Clinical Microbiology & Infectious Diseases;2018-11-15

4. Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study;PLOS ONE;2018-06-14